All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.
about
Retinoid signaling regulates breast cancer stem cell differentiation.Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.Retinoid mechanisms and cyclins.Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.Biodegradable Elastomers with Antioxidant and Retinoid-like PropertiesFunctional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of action.Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid.Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
P2860
Q33817989-CE89276D-B35F-477E-9F5B-1E820B64FD8BQ33940548-F5F6E201-666B-4F3C-98FD-A8E6A6FF2C00Q34272008-A11A1D28-749A-4D04-A6F7-70C6018FB531Q34345596-04C9A7B6-6FB7-4560-8F97-420BF30452BCQ36292446-5A0D5719-6B1A-46D8-9D2A-24CFD1FA82F8Q37028610-9DEE6BEC-A478-4A93-BD3C-7C0E7AFA4C06Q40106087-0FB9D0D0-2F2D-48D2-A1AF-E09C521647DFQ40426955-09288B61-7B8C-4965-9B70-066024BB8177Q40480988-0F7532C0-152B-4BDB-9C58-6C924B6F8208Q40608539-AE3E4AE4-C323-439C-9123-7090BF0A7C87Q40845247-2347070B-D448-437A-97C1-86CBF4D2D8C1Q44031836-7BD1240A-99B9-46DB-A287-F090F8952B7BQ44084210-077A445D-6A92-4274-A787-BB268AC9B883Q47388405-63EFA83C-A74A-46FD-9F9E-402393427372Q58544569-62319806-08DD-4506-A058-6F7DE44BAF70
P2860
All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@ast
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@en
type
label
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@ast
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@en
prefLabel
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@ast
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@en
P2093
P2860
P356
P1476
All-trans-retinoic acid metabo ...... breast cancer cells in vitro.
@en
P2093
Krekels MD
Ramaekers FC
Van heusden J
P2860
P2888
P356
10.1038/BJC.1998.5
P407
P577
1998-01-01T00:00:00Z
P5875
P6179
1018299079